MDAI


Also found in: Acronyms.

MDAI

A designer-type recreational drug which, in the pure form, is non-neurotoxic, acts as a highly selective serotonin reuptake inhibitor (SSRI) and serotonin-releasing agent, and has a high affinity for the serotonin transporter. It is pharmacologically and functionally similar to MDMA, and it has three distinct cues:
• Stimulant—as in methamphetamine;
• Hallucinogen—as in LSD;
• Entactogen—as in MBDB.
Some data suggest that it may be a more effective antidepressant than the current generation of SSRIs.
References in periodicals archive ?
At weeks 4 and 8, an mDAI was calculated, and at week 12 (study end point) a complete DAI was calculated.
Response at weeks 4 and 6 was defined as a reduction from baseline of at least 2 points on the mDAI.
Further information on the series is available at mdai.cat.
The next MDAI conference will be held August 16-18, 2007, in Kitakyushu, Japan.
MDAI, a substance which replicates the effects of ecstasy, is the next "legal high" in line to be banned.
MDAI 2006--Modeling Decisions for Artificial Intelligence.
Websites are now offering MDAI, which replicates the effects of ecstasy.
But MDAI, which was developed as an antidepressant at an American university, is being made available instead on the internet - and is so far perfectly legal.
Co-principal Paolo Deluca said: "Websites are already starting to promote MDAI and this could become the next popular product.
One website boasts: "New product for April - MDAI." Another says it is "proud to introduce a new compound to our product range".